Robert Naclerio to Administration, Intranasal
This is a "connection" page, showing publications Robert Naclerio has written about Administration, Intranasal.
Connection Strength
1.865
-
A Pragmatic Approach Towards Sinonasal Diseases. J Allergy Clin Immunol Pract. 2020 05; 8(5):1556-1558.
Score: 0.171
-
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
Score: 0.105
-
Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
Score: 0.092
-
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
Score: 0.092
-
Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
Score: 0.092
-
Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
Score: 0.091
-
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
Score: 0.081
-
Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb; 138(2):129-39.
Score: 0.074
-
Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
Score: 0.071
-
Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol. 2006 Mar-Apr; 20(2):191-6.
Score: 0.065
-
Alpha-adrenoreceptor blockade with phenoxybenzamine does not affect the ability of the nose to condition air. J Appl Physiol (1985). 2005 Jul; 99(1):128-33.
Score: 0.061
-
Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
Score: 0.061
-
Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
Score: 0.058
-
A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg. 2003 Feb; 128(2):220-7.
Score: 0.053
-
Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
Score: 0.048
-
Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
Score: 0.046
-
Dose-dependent effects of intranasal steroids: how relevant? Ann Allergy Asthma Immunol. 2000 Oct; 85(4):248-9.
Score: 0.045
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 10; 75(10):2440-2444.
Score: 0.045
-
Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
Score: 0.044
-
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
Score: 0.043
-
Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
Score: 0.037
-
Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
Score: 0.036
-
Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
Score: 0.033
-
Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
Score: 0.031
-
In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
Score: 0.031
-
A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
Score: 0.028
-
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
Score: 0.028
-
Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 1):373-6.
Score: 0.026
-
Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
Score: 0.025
-
The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
Score: 0.023
-
Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
Score: 0.022
-
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
Score: 0.021
-
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
Score: 0.018
-
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
Score: 0.018
-
In vivo model for the evaluation of topical antiallergic medications. Arch Otolaryngol. 1984 Jan; 110(1):25-7.
Score: 0.014
-
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
Score: 0.013
-
Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
Score: 0.009
-
A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
Score: 0.006
-
A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990 Nov; 162(5):1173-7.
Score: 0.006
-
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
Score: 0.003